Assignee
SCHEIBER LANE BERNARD
0 granted patents·26 pending applications·0 citations·filing 2007–2014
Top patents by PatentIndex Score
26 records- 0132US2009257998A1Method for treating heart attacks, strokes and diabetic crisis by utilizing modified virus virions to insert necessary protein molecules and vital nutrients into targeted cellsSCHEIBER LANE BERNARD·Filed 2008·Application pending·0 cites
- 0232US2009291118A1Universal barrier to prevent infections from human immunodeficiency virusSCHEIBER LANE BERNARD·Filed 2008·Application pending·0 cites
- 0332US2009257983A1Medical treatment device for treating aids by utilizing modified human immunodeficiency virus virions to insert anti-viral medications into t-helper cellsSCHEIBER LANE BERNARD·Filed 2008·Application pending·0 cites
- 0432US2009258879A1Method for treating cancer, rheumatoid arthritis and other medical diseases by utilizing modified virus virions to insert medications into targeted cellsSCHEIBER LANE BERNARD·Filed 2008·Application pending·0 cites
- 0532US2009246176A1Method for treating diabetes mellitus, obesity, chronic fatigue, aging, and other medical conditions by utilizing modified virus virions to insert messenger ribonucleic acid molecules into cellsSCHEIBER LANE BERNARD·Filed 2008·Application pending·0 cites
- 0632US2009297484A1Method for curing and preventing acquired immune deficiency syndrome by altering cell-surface receptors in precursor t-helper cells and mature t-helper cells to prevent human immunodeficiency virus virions access to mature helper cellsSCHEIBER LANE BERNARD·Filed 2008·Application pending·0 cites
- 0731US2009169599A1Scientifically modulated and reprogrammed treatment (smart) fas/fasl virus technology intended to neutralize t-helper cells infected with the human immunodeficiency virusSCHEIBER LANE BERNARD·Filed 2007·Application pending·0 cites
- 0831US2009220542A1Vaccine comprised specifically of protein subunits of human immunodeficiency virus's glycoprotein 120 probe to prevent and treat an infection caused by the human immunodeficiency virusSCHEIBER LANE BERNARD·Filed 2008·Application pending·0 cites
- 0923US2009257982A1medical device for treating diabetes mellitus, obesity, chronic fatigue, aging, and other medical conditions by utilizing modified virus virions to insert messenger ribonucleic acid molecules into cellsSCHEIBER LANE BERNARD·Filed 2008·Application pending·0 cites
- 1023US2009292233A1Anti-human immunodeficiency virus surrogate target agent technology filter intended to terminate t-helper cells infected with the human immunodeficiency virus circulating in bloodSCHEIBER LANE BERNARD·Filed 2008·Application pending·0 cites
- 1122US2009155883A1Scientifically Modulated And Reprogrammed Treatment (SMART) Virus Technology Intended to Neutralize the Human Immunodeficiency VirusSCHEIBER LANE BERNARD·Filed 2007·Application pending·0 cites
- 1222US2009291117A1Female barrier to prevent infections from human immunodeficiency virusSCHEIBER LANE BERNARD·Filed 2008·Application pending·0 cites
- 1320US2009281473A1Anti-Human Immunodeficiency Virus Surrogate Target Agent Technology Filter Intended to Neutralize or Remove Human Immunodeficiency Virus Virions From BloodSCHEIBER LANE BERNARD·Filed 2008·Application pending·0 cites
- 1420US2009175831A1Adaptable messenger ribonucleic acid medical treatment device to manage diabetes mellitusSCHEIBER LANE BERNARD·Filed 2008·Application pending·0 cites
- 1518US2015227682A1Method to represent the nucleotide elements of dna as numerical elements to include adenine being assigned the value zero, guanine being assigned the value one, cytosine being assigned the value two and thymine being assigned the value threeSCHEIBER LANE BERNARD·Filed 2014·Application pending·0 cites
- 1618US2015227684A1Method to represent the nucleotide elements of a dna sequence as numerical elements to include cytosine being assigned the value zero, thymine being assigned the value one, adenine being assigned the value two and guanine being assigned the value threeSCHEIBER LANE BERNARD·Filed 2014·Application pending·0 cites
- 1718US2015227678A1Method to represent the nucleotide elements of a dna sequence as numerical elements to include adenine being assigned the value one, guanine being assigned the value two, cytosine being assigned the value three, and thymine being assigned the value fourSCHEIBER LANE BERNARD·Filed 2014·Application pending·0 cites
- 1818US2015227683A1Method to represent the nucleotide elements of a dna sequence as numerical elements to include cytosine being assigned the value one, thymine being assigned the value two, adenine being assigned the value three, and guanine being assigned the value fourSCHEIBER LANE BERNARD·Filed 2014·Application pending·0 cites
- 1915US2011212177A1Configurable microscopic medical payload delivery device to deliver medically therapeutic payloads to specifically targeted cell typesSCHEIBER LANE BERNARD·Filed 2010·Application pending·0 cites
- 2015US2011293694A1Quantum unit of inheritance vector therapy methodSCHEIBER LANE BERNARD·Filed 2010·Application pending·0 cites
- 2115US2011293693A1Quantum unit of inheritance vector therapySCHEIBER LANE BERNARD·Filed 2010·Application pending·0 cites
- 2215US2011294996A1Quantum unit of inheritanceSCHEIBER LANE BERNARD·Filed 2010·Application pending·0 cites
- 2315US2011236466A1Chemo vector therapy to deliver chemotherapy molecules to specific cells to manage breast cancer, other cancers and inflammatory disordersSCHEIBER LANE BERNARD·Filed 2010·Application pending·0 cites
- 2411US2011237653A1Rna vector therapy methodSCHEIBER LANE BERNARD·Filed 2010·Application pending·0 cites
- 2510US2011236483A1Rna vector therapySCHEIBER LANE BERNARD·Filed 2010·Application pending·0 cites
- 267US2011212160A1Configurable microscopic medical payload delivery device to deliver nuclear signaling proteins to specific cells to manage diabetes mellitus and genetic deficiency disordersSCHEIBER LANE BERNARD·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when SCHEIBER LANE BERNARD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →